InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024
May 28, 2024 08:53 ET
|
InspireMD, Inc.
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection device pivotal trial Study results to support a...
Mitch Hutchcraft Joins Alico, Inc. as Executive Vice President of Real Estate
May 28, 2024 08:50 ET
|
Alico, Inc.
FORT MYERS, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico”) has announced that Mitch Hutchcraft is joining the company in a newly created position as Executive Vice President of Real...
Wearable Devices XR Team's Report: The Mudra’s Neural Technology to Power Future XR Devices
May 28, 2024 08:45 ET
|
Wearable Devices Ltd.
The comprehensive review highlights Mudra Band’s precision in fingertip pressure measurement, revolutionizing interaction with Apple Vision Pro and Meta Quest 3 YOKNEAM ILLIT, ISRAEL, May 28,...
Aprea Therapeutics Announces that Safety Review Committee (SRC) Endorses Dosing of Patients with ATRN-119 at 800 mg Once Daily in Ongoing ABOYA-119 Clinical Trial
May 28, 2024 08:45 ET
|
Aprea Therapeutics
ATRN-119 is the first and only macrocyclic ATR inhibitor in the clinic, with best in class potential On track to complete dose escalation in ABOYA-119 clinical trial and potentially generate initial...
Mama’s Creations to Host First Quarter and Fiscal Year 2025 Earnings Call on June 11 at 4:30 p.m. Eastern Time
May 28, 2024 08:31 ET
|
Mama’s Creations, Inc.
EAST RUTHERFORD, NJ, May 28, 2024 (GLOBE NEWSWIRE) -- Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh Deli prepared foods, will release financial results...
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma
May 28, 2024 08:30 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing...
Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets
May 28, 2024 08:30 ET
|
Mangoceuticals, Inc.
Dallas, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health...
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
May 28, 2024 08:30 ET
|
Xenon Pharmaceuticals Inc.
VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced data presentations highlighting...
SRIVARU (SVMH) Announces the Completion of State-of-the-Art Factory and Fully Automated EV Motorcycle Manufacturing Facility
May 28, 2024 08:30 ET
|
SRIVARU Holding
GRAND CAYMAN, Cayman Islands and COIMBATORE, India, May 28, 2024 (GLOBE NEWSWIRE) -- SRIVARU Holding Limited (Nasdaq: SVMH; SVMHW) (“SRIVARU” or the “Company”), a provider of premium electric...
Nano Dimension Is Partnering with Esko and Fiery to Provide an End-To-End Industry 4.0 Solution
May 28, 2024 08:30 ET
|
Nano Dimension Ltd.
The Company’s Global Inkjet Systems (“GIS”) Products Are Integrating to Provide Manufacturers with a Comprehensive, One-Stop-Shop Digital Print Solution Waltham, Mass., May 28, 2024 (GLOBE...